B-type natriuretic peptide shows a graded association with decline in kidney function in individuals with diabetes, even at concentrations ≤ 18.4 pg/mL, which are conventionally considered normal.
Background The formation of cardiac fibroid deposits due to intense exercise may be involved in cardiac arrhythmias. Galectin-3 (Gal-3) and suppression of tumorogenicity2 (ST2) are considered as ...
The report Cardiac Marker Testing Market size is estimated to be USD 3.6 billion in 2020 and projected to reach USD 5.5 billion by 2025, at a CAGR of 8.9. The growing incidence of cardiovascular ...
New York, Aug. 15, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cardiac Marker Testing Market Research Report by Type, by Product, by Disease, by Type of Testing - ...
Consistent association seen for markers of systolic dysfunction with smaller total brain volume. (HealthDay News) — Subclinical cardiac dysfunction is associated with brain imaging markers of ...
The "Global Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, ...
Providing consolidation of both routine and new cardiac markers with several STAT analytes with the new Thermo Scientific™ MAS ® Omni•CARDIO™ FREMONT, Calif.--(BUSINESS WIRE)--Clinical laboratory ...
The Cardiac Marker Testing Market is estimated to be USD 3.6 billion in 2020 and projected to reach USD 5.5 billion by 2025, at a CAGR of 8.9%. According to the new market research report "Cardiac ...
DUBLIN, Feb. 1, 2021 /PRNewswire/ -- The "Global Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results